Previous Next

News Releases    Medical/Health Care

Translations: 


Medical/Health Care Results: 785 item(s)
DARMSTADT, Germany, Dec. 11, 2017 /PRNewswire-AsiaNet/ -- - Merck to distribute top lipid portfolio outside of United States - Improves customer access through e-commerce platform Merck [https://www.merckgroup.com/en ] , a leading science and technology company, today announced that it ha...
BAGSVAERD, Denmark, Dec. 11 /PRNewswire-AsiaNet/ -- Results published in Diabetes, Obesity and Metabolism Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diab...
WALTHAM, Mass., Dec. 11, 2017 /PRNewswire-AsiaNet/ -- - At 24 months Ropeginterferon alfa-2b: Demonstrated superiority over best available treatment Achieved high rates and durable clinical and hematological response Confirmed favorable safety and tolerability profile beyond 24 months Further dem...
SINGAPORE, Dec. 11, 2017 /PRNewswire-AsiaNet/ -- Fullerton Healthcare Corporation Limited (Fullerton Health) today announced that it has entered into agreements to acquire a 60% stake in the Intellicare Group, one of the leading managed care providers in the Philippines. The Philippines is an im...
WALTHAM, Massachusetts, Dec. 10, 2017 /PRNewswire-AsiaNet/ -- -- At 24 months Ropeginterferon alfa-2b: Demonstrated superiority over best available treatment Achieved high rates and durable clinical and hematological response Confirmed favorable safety and tolerability profile beyond 24 mo...
DARMSTADT, Germany, Dec 7, 2017/PRNewswire-AsiaNet/ -- Not intended for U.K./U.S. based media - First treatment in relapsing-remitting multiple sclerosis (RRMS) to show sustained clinical efficacy for up to 4 years with a maximum of 20 days of oral treatment over 2 years - Updated registra...
DOHO, Qatar, Dec. 7, 2017 /PRNewswire-AsiaNet/ -- This year, the 3rd [http://jpmorgan.metameetings.com/confbook/healthcare16/login.php ] international PHCC conference under the patronage of Her Excellency Dr Hanan Mohamed Al Kuwari is the Minister of Public Health for the State of Qatar rich...
ABU DHABI, UAE, Dec. 7, 2017 /PRNewswire-AsiaNet/ -- People with either type 1 or type 2 diabetes treated with Tresiba(R) had fewer episodes of low blood sugar (hypoglycaemia) compared with people on insulin glargine U100 regardless of whether they had achieved blood sugar targets.[1] Thes...
ABU DHABI, UAE, Dec. 7, 2017 /PRNewswire-AsiaNet/ -- In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate of low blood sugar (hypoglycaemia) including severe episodes by 62% and the rate of nocturnal hypoglycaemia by 74% versus...
ABU DHABI, UAE, Dec. 6, 2017 /PRNewswire-AsiaNet/ -- - Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes[1] - 1 in 3 respondents considered themselves to be at low risk of CVD[2] - 1 in 6 respondents had never discussed type 2 diabetes and ...

Previous Page Page 1 of 79 Next Page 1  2  3  4  5  6  7  8  9  10  ... Go to page Go